Prostate cancer: to screen or not to screen?
作者信息
Schröder F H
出版信息
BMJ. 1993 Feb 13;306(6875):407-8. doi: 10.1136/bmj.306.6875.407.
Abstract
摘要
相似文献
1
Prostate cancer: to screen or not to screen?前列腺癌：筛查还是不筛查？
BMJ. 1993 Feb 13;306(6875):407-8. doi: 10.1136/bmj.306.6875.407.
2
To screen or not to screen: cancer of the prostate.筛查还是不筛查：前列腺癌
Contemp Nurse. 1994 Sep;3(3):127-30.
3
[Proposal for mass screening in cancer of the prostate].[前列腺癌大规模筛查提案]
Minerva Urol Nefrol. 1987 Oct-Dec;39(4):325-8.
4
Prostate cancer: enthusiasm for screening.前列腺癌：对筛查的热情。
Med J Aust. 1995 May 15;162(10):540-1.
5
Progress in the control of prostate cancer in Rhode Island, 1987-2000.1987 - 2000年罗德岛州前列腺癌控制进展
Med Health R I. 2002 Sep;85(9):291-3.
6
Screening for prostate cancer: are we ready?前列腺癌筛查：我们准备好了吗？
Cancer Epidemiol Biomarkers Prev. 1994 Apr-May;3(3):193-5.
7
The identification and screening of men at high risk for developing prostate cancer.前列腺癌高危男性的识别与筛查。
Urol Nurs. 2000 Feb;20(1):15-8, 23-4, 46.
8
Is screening for prostate cancer the current gold standard?--"no".前列腺癌筛查是当前的金标准吗？——“不是”。
Eur J Cancer. 1997 Mar;33(3):348-53.
9
10
Prostate cancer in North Carolina.北卡罗来纳州的前列腺癌。
N C Med J. 1992 Sep;53(9):447-51.
引用本文的文献
1
Active surveillance for prostate cancer: a legal perspective.前列腺癌的主动监测：法律视角
Am J Clin Exp Urol. 2014 Dec 25;2(4):323-31. eCollection 2014.
2
[The diagnostic situation with prostatic cancer in primary care].[基层医疗中前列腺癌的诊断情况]
Aten Primaria. 2000 Feb 28;25(3):137-41. doi: 10.1016/s0212-6567(00)78476-9.
3
Towards a philosophy of public health.走向公共卫生哲学。
J Epidemiol Community Health. 1999 Feb;53(2):99-104. doi: 10.1136/jech.53.2.99.
4
Screening for prostatic cancer.前列腺癌筛查
BMJ. 1993 Apr 24;306(6885):1129-30. doi: 10.1136/bmj.306.6885.1129-b.
5
Screening for prostatic cancer.前列腺癌筛查
BMJ. 1993 Mar 27;306(6881):856. doi: 10.1136/bmj.306.6881.856-a.
6
Screening for prostatic cancer.前列腺癌筛查
BMJ. 1993 Mar 27;306(6881):855; author reply 856. doi: 10.1136/bmj.306.6881.855-a.
7
Screening for prostatic cancer.前列腺癌筛查
BMJ. 1993 Mar 27;306(6881):855. doi: 10.1136/bmj.306.6881.855.
8
Costs of screening are important.筛查成本很重要。
BMJ. 1993 Mar 20;306(6880):797. doi: 10.1136/bmj.306.6880.797.
9
Screening for prostatic cancer.前列腺癌筛查
BMJ. 1993 Mar 27;306(6881):855-6. doi: 10.1136/bmj.306.6881.855-b.
10
Radical prostatectomy and prostate cancer screening: the need for national audit and research.根治性前列腺切除术与前列腺癌筛查：全国性审计与研究的必要性
Ann R Coll Surg Engl. 1994 Nov;76(6):367-72.
本文引用的文献
1
Latent carcinoma of the prostate.前列腺潜伏癌
J Pathol Bacteriol. 1954 Oct;68(2):603-16. doi: 10.1002/path.1700680233.
2
Stage D1 adenocarcinoma of prostate.前列腺D1期腺癌
Urology. 1984 Feb;23(2):118-21. doi: 10.1016/0090-4295(84)90002-5.
3
Total prostatectomy for clinically localized prostatic cancer: long-term results.临床局限性前列腺癌根治性前列腺切除术：长期结果
J Urol. 1989 Mar;141(3):564-6. doi: 10.1016/s0022-5347(17)40895-0.
4
A controlled trial of leuprolide with and without flutamide in prostatic carcinoma.
N Engl J Med. 1989 Aug 17;321(7):419-24. doi: 10.1056/NEJM198908173210702.
5
Radical prostatectomy in locally confined prostatic carcinoma.局限性前列腺癌的根治性前列腺切除术。
Prog Clin Biol Res. 1990;359:199-207; discussion 223-9.
6
Cancer in the European Community and its member states.欧洲共同体及其成员国的癌症情况。
Eur J Cancer. 1990;26(11-12):1167-256. doi: 10.1016/0277-5379(90)90278-2.
7
Current urological practice: routine urological examination and early detection of carcinoma of the prostate.
J Urol. 1992 Aug;148(2 Pt 1):326-9; discussion 329-30. doi: 10.1016/s0022-5347(17)36585-0.
8
Distribution of Leu-7 antigen (HNK-1) in thyroid tumors: its usefulness as a diagnostic marker for follicular and papillary carcinomas.亮氨酸-7抗原（HNK-1）在甲状腺肿瘤中的分布：其作为滤泡状癌和乳头状癌诊断标志物的用途。
Hum Pathol. 1992 Jan;23(1):21-5. doi: 10.1016/0046-8177(92)90005-n.
Zotero 插件